Co-Authors
This is a "connection" page, showing publications co-authored by Dominic Esposito and Jennifer Mehalko.
Connection Strength
1.489
-
Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays. Protein Expr Purif. 2021 03; 179:105802.
Score: 0.915
-
Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays. Protein Expr Purif. 2020 10; 174:105686.
Score: 0.221
-
Refining the N-Termini of the SARS-CoV-2 Spike Protein and Its Discrete Receptor-Binding Domain. J Proteome Res. 2021 09 03; 20(9):4427-4434.
Score: 0.060
-
Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States. Sci Transl Med. 2021 07 07; 13(601).
Score: 0.060
-
A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2. JCI Insight. 2021 04 22; 6(8).
Score: 0.059
-
Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses. J Clin Immunol. 2021 07; 41(5):906-913.
Score: 0.058
-
Effect of D614G Spike Variant on Immunoglobulin G, M, or A Spike Seroassay Performance. J Infect Dis. 2021 03 03; 223(5):802-804.
Score: 0.058
-
Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling. Nat Commun. 2021 01 04; 12(1):113.
Score: 0.058